The traditional healthcare system offered a reactive model: when you fall ill, you visit a…
TechPharus
Latest Posts
Blueprint for Tomorrow: Abu Dhabi’s Genomic Vision for Healthcare
Abu Dhabi is leading a genomic revolution that promises to reshape healthcare by deeply understanding…
The UAE’s Expanding Life Sciences Ecosystem: A New Global Powerhouse
The UAE’s healthcare and life-science sector is experiencing rapid growth, powered by a robust ecosystem…
Building the Future of Pharma: Abu Dhabi’s Strategic Leap
Abu Dhabi’s Pharmaceutical Sector: Rising to Global Prominence Over the past decade, Abu Dhabi—one of…
How the UAE is Shaping the Future of Longevity and Healthspan
The United Arab Emirates is swiftly positioning itself as a global leader in the Longevity…
Interview with Dr. Priyanka Mathur, MediPocket World
We recently spoke to Dr. Priyanka Mathur, a visionary healthcare leader with international healthcare experience…
HealthTech News
- Platelet-rich plasma, shockwave therapy show therapeutic efficacy in interstitial cystitison July 31, 2026 at 7:40 pm
For patients with interstitial cystitis (IC)/bladder pain syndrome (BPS), the combination of platelet-rich plasma (PRP) and low-intensity extracorporeal shock wave therapy (LI-ESWT) shows therapeutic efficacy, according to a study recently published in Frontiers in Bioengineering and Biotechnology.
- Liver tumors may depend on LARS to withstand stress and keep multiplyingon July 31, 2026 at 7:20 pm
Illinois researchers made a breakthrough discovery in the fight against liver cancer. Collaborators Lin-Feng Chen, Susan A. Martinis, and graduate student Xiaodan Lin found that decreasing protein levels of leucyl-tRNA synthetase (LARS) impedes liver cancer cell multiplication.
- Cannabinoid pathways may offer targets for kidney disease as CKD affects 850 million peopleon July 31, 2026 at 7:00 pm
Approximately 850 million people globally (9.1% of the world’s population) have chronic kidney disease (CKD). The number of affected individuals has grown steadily during the past 20 years and is on track to continue rising. Existing drugs, such as RAAS inhibitors and angiotensin receptor blockers, are commonly prescribed, but their effectiveness varies from patient to patient. Moreover, these drugs can slow disease progression but cannot stop it.
- Beyond ‘healthy’ obesity: New framework weighs organ damage and daily limitationson July 31, 2026 at 6:20 pm
A new approach to defining obesity could help physicians better determine which patients need more intensive treatment by focusing on the effects of excess adiposity on organs and tissues rather than relying primarily on whether a person meets a set of metabolic risk thresholds.
- For mind and body: Community gathering places may counteract cognitive disabilityon July 31, 2026 at 6:00 pm
Community gathering places, where residents lead group activities, have been promoted across Japan as part of long-term care prevention efforts to extend healthy life expectancy. These often involve exercise and social interaction and are meant to help prevent cognitive decline. However, previous studies have reported inconsistent findings regarding their association with cognitive disability.




